Angela Hargrove, MHA

Specialized in Psychedelic Research & CNS Clinical Trials

Connecting innovative therapies with the right research partners to advance mental health treatments that transform lives.

Schedule a Consultation

About Angela

Angela Hargrove
30+ YEARS OF EXCELLENCE

With over three decades in clinical research and healthcare, I've pioneered groundbreaking studies in CNS and psychedelic therapies while forging strategic partnerships between sites, CROs, and sponsors.

My Personal Connection

My passion for this field is deeply personal—psychedelic therapy saved my husband's life, inspiring my commitment to advancing these revolutionary treatments through rigorous clinical research.

Professional Approach

I bring both scientific rigor and business acumen to every project, connecting promising treatments with the right research partners to bring life-changing therapies to those who need them most. My extensive industry network enables strategic partnerships that advance innovative treatments.

Consulting Services

Site Identification & Selection

Leveraging 30+ years of industry relationships to identify optimal research sites that deliver high-quality data and efficient recruitment for your clinical trials.

CRO-Sponsor Matchmaking

Creating strategic partnerships between sponsors and the right CRO partners with specialized expertise in your therapeutic area.

Psychedelic Research Programs & Dosing Room Design

Specialized expertise in navigating the unique regulatory and operational challenges of psychedelic clinical research. Deep exertise in designing dosing rooms and building new psychedelic researh programs.

Strategic Trial Placement

Optimizing protocol feasibility and patient recruitment strategies to ensure successful study execution.

Business Development Consulting

Revenue growth strategies for research organizations looking to expand their clinical trial portfolios.

Medical Writing & Protocol Design

Our experienced team can assist with comprehensive medical writing and protocol design services, creating scientifically sound, operationally feasible study protocols tailored to your specific research objectives and regulatory requirements.

Professional Experience

Strategic Leadership in Clinical Research

As a Vice President of Business Development with over three decades of industry expertise, I've led strategic initiatives across multiple CROs and research organizations, specializing in CNS and psychedelic therapies.

Leadership Experience

  • Vice President, Business Development at Clinilabs
  • Senior Director, Business Development at Emmes Group
  • Senior Director, Business Development at Elligo Health Research
  • Senior Director, Business Development at Apex Innovative Sciences (now CenExel)
  • Director, Business Development at RMPDS/Denver Health

Key Achievements

  • Led $39 million single study with major pharmaceutical sponsor
  • Pioneered largest psychedelics clinical trial network in the industry
  • Secured key partnerships with major organizations including MAPS
  • Built a six-figure healthcare consulting practice from ground up

Specialized Expertise

  • Psychedelic therapies and innovative trial design
  • CNS, psychiatry, and mental health
  • CRO-Sponsor relationship development
  • Site identification, selection, and management

Additional Experience

  • Owner/Founder of WellCare Solutions, LLC
  • Director, Business Development at Universal Health Services, Inc.
  • Early career as Clinical Research Associate (CRA) at GlaxoSmithKline (all phases)

Testimonials

"
Andrew Wolf

Andrew Wolf

Founder/CEO of AllyMack

"Angela is a great science and topic expert in matters related to psychedelics and therapy. Her range of expertise and interests allows her to interact with a wide range of professionals from all walks of life."

"
Don Turner

Don Turner

CEO, Neosinus Health

"Angela is the quintessential business leader who truly cares about building strong business relationships that are mutually beneficial. She has those unique business talents that are hard to find and difficult to teach."

"
Adam Brown Sr.

Adam Brown Sr.

CEO, Public Health

"She is a go-getter, extremely knowledgable in her craft, and understands the nuances of the clinical trials process. She genuinely wants to make a difference in her professional and personal life."

"
Shayne Nyquvest

Shayne Nyquvest

Founder, Universal Ibogaine

"Angela speaks from first-hand knowledge of Ibogaine's therapeutic properties. She is passionate about helping others and the psychedelic industry. I offer Angela my highest recommendation."

"
Kate Reynolds

Kate Reynolds

Director of Research, RMPDS

"Angela is best in class in her knowledge of postmarketing services and the sales cycle. She has brought an energy to RMPDS, and we are excited to have her as part of our team!"

"
Richard Dart

Richard Dart

Executive Director, RMPDS

"Her excellent relationships with our sponsors has been instrumental in bringing us new opportunities in emerging markets. She has taken our efforts to a new level."

"
Chris Claussen

Chris Claussen

Founder & Chief Innovation Officer

"She possesses strong industry knowledge and initiated the entire sales cycle. She is very passionate about healthcare, psychedelic therapeutics and helping her clients. She is a gem!"

"
Tammy Le

Tammy Le

The Heroic Hearts Project

"The most passionate and effective in this emerging space are those who have had profound experiences themselves or with loved ones and can see how psychedelics can be one of the most powerful agents of healing."

Recent Publications

Breaking Historic Barriers to Ensure Psychedelic Therapy's Future

Applied Clinical Trials, November 2023

Read Publication →

What the FDA's Groundbreaking Guidance Really Means for Psychedelic Therapy Clinical Trials

Pharmaphorum, November 2023

Read Publication →

Psychedelic Therapy Saved My Husband's Life. How Can We Save More?

Association of Clinical Research Professionals (ACRP), December 2023

Read Publication →

Navigating Setbacks: The FDA Rejection of MDMA Therapy & the Road Ahead for Psychedelics

Contract Pharma, September 2024

Read Publication →

My Advocacy

My advocacy for advancing psychedelic therapies in mental health treatment is deeply personal. When my husband found healing through ibogaine treatment for addiction, I witnessed firsthand how these innovative therapies can transform lives.

When you free a parent from addiction, you create a pathway for the entire family to heal and prosper. This ripple effect of recovery is what drives my commitment to expanding access to these treatments.

I advocate for families impacted by addiction, knowing that treating one person creates healing opportunities for children, partners, and extended family members. Our family's journey from struggle to prosperity demonstrates the far-reaching benefits of effective treatment.

I'm a passionate supporter of our military veterans gaining access to these critical medications. Those who've served our country deserve innovative treatments for PTSD, depression, and substance use disorders that conventional approaches haven't adequately addressed.

Through speaking engagements, publications, and direct work with stakeholders, I strive to create pathways for responsible research and eventual approval of psychedelic therapies, ensuring they can be safely administered to those who need them most.

My Testimony on Ibogaine Treatment

My testimony before the Kentucky Opioid Abatement Advisory Commission on the transformative power of psychedelic therapies.

Contact Angela

Let's Connect

Interested in discussing how my expertise can advance your clinical research goals? Reach out directly or schedule a meeting.

📧
📱
Phone

(859) 537-4238

📍
Location

Ponte Vedra Beach, Florida

Schedule a Meeting

Select a convenient time for us to discuss your clinical research needs.

View My Calendar